EP1930003A1 — Pharmaceutical form containing methocarbamol, meloxicam and betamethasone
Assigned to World Trade Import Export Wtie AG · Expires 2008-06-11 · 18y expired
What this patent protects
The present invention relates generally to the pharmaceutical industry, and particularly to the pharmaceutical industry dedicated to the preparation of medicaments for the treatment of exacerbations and acute cases of patients suffering from rheumatoid arthritis, ankylosing spond…
USPTO Abstract
The present invention relates generally to the pharmaceutical industry, and particularly to the pharmaceutical industry dedicated to the preparation of medicaments for the treatment of exacerbations and acute cases of patients suffering from rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, pain and inflammation relief from acute gouty arthritis, acute and subacute bursitis, tendonitis, synovitis.
Drugs covered by this patent
- Robaxin (METHOCARBAMOL) · Hikma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.